biotech
Syntimmune brings in new CEO from Biogen
January 4, 2018Syntimmune, biotech, drugs, pharma, pharmaceutical
Syntimmune has revealed that it has brought in a new CEO to begin the new year, with the appointment of …
Spark’s bright idea on $850,000 blindness gene therapy
January 3, 2018Sales and Marketing : Pharma, Spark Therapeutics, biotech, drugs, pharma, pharmaceutical
Spark Therapeutics knew that it had to think very carefully about where it pitched its price for its inarguably ground-breaking …
J&J’s predicted blockbuster depression posts P2 data
January 3, 2018Research and Development Johnson & Johnson, biotech, depression, drugs, pharma, pharmaceutical
Johnson & Johnson has revealed Phase 2 data for its treatment for depression, esketamine, and the results are positive. The …
Novartis’ Kisqali gains breakthrough status in premenopausal breast cancer
January 3, 2018Research and Development, Sales and Marketing Kisqali, Novartis, biotech, drugs, pharma, pharmaceutical
Novartis has received a major boost in its efforts to broaden use of its CDK4/6 inhibitor, by receiving a breakthrough …
Winter crisis hits, NHS hospitals cancel non-emergency operations
January 3, 2018Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical
There was ample warning that the NHS looked set to face another difficult winter season, the predictions now look to …
Diabetes drugs show potential in treating Alzheimer’s
January 3, 2018Research and Development Alzheimer's disease, biotech, drugs, pharma, pharmaceutical
A group of researchers at Lancaster University have identified a drug currently used to treat type 2 diabetes that has …
GW Pharma applies to both EU and US for lead product
January 2, 2018Manufacturing and Production, Sales and Marketing GW Pharma, biotech, drugs, pharma, pharmaceutical
GW Pharmaceuticals had a busy festive period, after it announced that it had submitted to both the EU and the …
NICE to take another look at Pfizer’s leukaemia drug
January 2, 2018Manufacturing and Production, Sales and Marketing NICE, Pfizer, biotech, drugs, pharma, pharmaceutical
Back in August of 2017, NICE rejected Pfizer’s Besponsa on cost-effectiveness grounds and the pharma giant was not best pleased. …
FDA approves shock wave wound healing device
January 2, 2018Manufacturing and Production, Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical
Continuing its recent trend to promote innovative new technologies, the FDA has announced that it has approved a medical device …
Mylan and Biocon biosimilar approval expands to Brazil
January 2, 2018Manufacturing and Production, Sales and Marketing Biocon, Herceptin, Mylan, biosimilar, biotech, drugs, pharma, pharmaceutical
Since Mylan and Biocon managed to gain US FDA approval for its Herceptin (Trastuzumab) biosimilar, it has forged ahead in …
Valeant and Pershing take $290m hit over insider trading
January 2, 2018Manufacturing and Production, Sales and Marketing Bill Ackman, Pershing Square, Valeant, biotech, drugs, pharma, pharmaceutical
Valeant Pharmaceuticals will be hoping it can begin 2018 as a fresh start, after a turbulent few years, to say …
Novartis hit by court loss, could spur numerous cases across industry
December 22, 2017Medical Communications, Sales and Marketing Novartis, biotech, drugs, pharma, pharmaceutical
In a landmark ruling, a Californian court has found that a brand name manufacturer of a drug could be held …
Roche boosts oncology portfolio with $1.7bn acquisition
December 22, 2017Medical Communications, Sales and Marketing Roche, biotech, drugs, ignyta, pharma, pharmaceutical
Roche has announced that it will buy Ignyta, a San Diego-based biotech that has a pipeline of oncology drugs, for …
Eisai and Biogen Alzheimer’s drug stumbles at P2
December 21, 2017Medical Communications, Research and Development Biogen, Eisai, biotech, drugs, pharma, pharmaceutical
Only a few months ago, it was announced that Eisai had decided to opt into the development process of BAN2401. …
The rare disease climate in Europe
December 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, rare disease
Continuing on from this week’s earlier feature on the rare disease situation in the US, Pharmafile moves its attention onto …
Latest content
